Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients.

Huisinga JM, Pipinos II, Johanning JM, Stergiou N.

J Neuroeng Rehabil. 2010 Jun 7;7:25. doi: 10.1186/1743-0003-7-25.

2.

Treatment with pharmacological agents in peripheral arterial disease patients does not result in biomechanical gait changes.

Huisinga JM, Pipinos II, Stergiou N, Johanning JM.

J Appl Biomech. 2010 Aug;26(3):341-8.

PMID:
20841626
3.

Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.

Yentes JM, Huisinga JM, Myers SA, Pipinos II, Johanning JM, Stergiou N.

J Appl Biomech. 2012 May;28(2):184-91.

4.

Cilostazol for intermittent claudication.

Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G.

Cochrane Database Syst Rev. 2014 Oct 31;(10):CD003748. doi: 10.1002/14651858.CD003748.pub4. Review.

PMID:
25358850
6.

Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication.

Koutakis P, Pipinos II, Myers SA, Stergiou N, Lynch TG, Johanning JM.

J Vasc Surg. 2010 Jan;51(1):80-8. doi: 10.1016/j.jvs.2009.07.117. Epub 2009 Oct 17.

7.

Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease.

Crowther RG, Spinks WL, Leicht AS, Sangla K, Quigley F, Golledge J.

J Vasc Surg. 2008 Feb;47(2):303-9. doi: 10.1016/j.jvs.2007.10.038.

8.

The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease.

O'Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV.

J Vasc Surg. 2009 May;49(5):1226-34. doi: 10.1016/j.jvs.2008.11.098. Epub 2009 Feb 14.

9.

Gait variability is altered in patients with peripheral arterial disease.

Myers SA, Johanning JM, Stergiou N, Celis RI, Robinson L, Pipinos II.

J Vasc Surg. 2009 Apr;49(4):924-931.e1. doi: 10.1016/j.jvs.2008.11.020. Epub 2009 Feb 14.

10.

Peripheral arterial disease affects kinematics during walking.

Celis R, Pipinos II, Scott-Pandorf MM, Myers SA, Stergiou N, Johanning JM.

J Vasc Surg. 2009 Jan;49(1):127-32. doi: 10.1016/j.jvs.2008.08.013. Epub 2008 Nov 22.

11.

The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease.

O'Donnell ME, Badger SA, Sharif MA, Makar RR, Young IS, Lee B, Soong CV.

Vasc Endovascular Surg. 2009 Apr-May;43(2):132-43. doi: 10.1177/1538574408328586. Epub 2009 Jan 8.

PMID:
19131370
12.

Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication.

McDermott MM, Ohlmiller SM, Liu K, Guralnik JM, Martin GJ, Pearce WH, Greenland P.

J Am Geriatr Soc. 2001 Jun;49(6):747-54.

PMID:
11454113
13.

Safety and efficacy of cilostazol in the management of intermittent claudication.

Chi YW, Lavie CJ, Milani RV, White CJ.

Vasc Health Risk Manag. 2008;4(6):1197-203. Review.

14.

Bilateral claudication results in alterations in the gait biomechanics at the hip and ankle joints.

Chen SJ, Pipinos I, Johanning J, Radovic M, Huisinga JM, Myers SA, Stergiou N.

J Biomech. 2008 Aug 7;41(11):2506-14. doi: 10.1016/j.jbiomech.2008.05.011. Epub 2008 Jun 30.

PMID:
18586253
15.

Lack of relationship between gait parameters and physical function in peripheral arterial disease.

Scherer SA, Hiatt WR, Regensteiner JG.

J Vasc Surg. 2006 Oct;44(4):782-8.

16.

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.

Br J Surg. 2012 Dec;99(12):1630-8. doi: 10.1002/bjs.8895. Epub 2012 Oct 3. Review.

PMID:
23034699
17.

Intralimb coordination variability in peripheral arterial disease.

Crowther RG, Spinks WL, Leicht AS, Quigley F, Golledge J.

Clin Biomech (Bristol, Avon). 2008 Mar;23(3):357-64. Epub 2007 Dec 3.

PMID:
18061322
18.

The effect of claudication pain on temporal and spatial gait measures during self-paced ambulation.

Gardner AW, Montgomery PS, Ritti-Dias RM, Forrester L.

Vasc Med. 2010 Feb;15(1):21-6. doi: 10.1177/1358863X09106836. Epub 2009 Sep 25.

19.

Amino acids stimulate leg muscle protein synthesis in peripheral arterial disease.

Killewich LA, Tuvdendorj D, Bahadorani J, Hunter GC, Wolfe RR.

J Vasc Surg. 2007 Mar;45(3):554-9; discussion 559-60.

20.

Peripheral arterial disease affects the frequency response of ground reaction forces during walking.

McGrath D, Judkins TN, Pipinos II, Johanning JM, Myers SA.

Clin Biomech (Bristol, Avon). 2012 Dec;27(10):1058-63. doi: 10.1016/j.clinbiomech.2012.08.004. Epub 2012 Sep 9.

Supplemental Content

Support Center